Yiling Pharmaceutical Co., Ltd.: approved for clinical research of traditional Chinese medicine formula granules
-
Last Update: 2019-01-02
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
On January 1, Yiling pharmaceutical announced that the company had obtained the approval of Hebei drug administration and agreed to organize the production of 409 traditional Chinese medicine formula granule varieties such as dwarf tea declared by the company in accordance with the technology and quality standards approved by the expert technical review It is agreed that the company will carry out clinical research on TCM formula granules in hospitals above grade II and grade A (including grade II and grade A) in Hebei Province, with a trial period of one year The full text of the announcement is as follows:
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
